SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (9010)6/3/1998 6:51:00 PM
From: VLAD  Read Replies (3) of 23519
 
Tuna,

I did notice today that the main market maker buying Vivus stock throughout most of the day was First Boston. They have an analyst following Vivus. I bet that as soon as the good news starts coming out for Vivus (higher script numbers, factory approval, and more international sales) and more Viagra deaths are reported, then First Boston will make a strong buy recommendation. Thats right, keep quiet and accumulate as much as possible while the press temporarily creams the stock. It's kind of sad how investors have to worry more about agendas than fundamentals. This stock is for sheep and not investors--at least not the way this game is played.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News